Trade Inovio Pharmaceuticals, Inc. - INO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0522 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.001 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.8889 |
| Open | 1.8639 |
| 1-Year Change | -81.62% |
| Day's Range | 1.8189 - 1.8989 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 1.8389 | -0.0350 | -1.87% | 1.8739 | 1.8989 | 1.8189 |
| Apr 24, 2025 | 1.8889 | 0.0400 | 2.16% | 1.8489 | 1.8989 | 1.8289 |
| Apr 23, 2025 | 1.8389 | -0.0500 | -2.65% | 1.8889 | 1.9139 | 1.8189 |
| Apr 22, 2025 | 1.8189 | 0.0250 | 1.39% | 1.7939 | 1.8289 | 1.7539 |
| Apr 21, 2025 | 1.7589 | 0.0400 | 2.33% | 1.7189 | 1.8889 | 1.7189 |
| Apr 17, 2025 | 1.7189 | 0.0350 | 2.08% | 1.6839 | 1.7289 | 1.6689 |
| Apr 16, 2025 | 1.6989 | -0.0250 | -1.45% | 1.7239 | 1.7439 | 1.6489 |
| Apr 15, 2025 | 1.7289 | -0.0100 | -0.58% | 1.7389 | 1.8089 | 1.7089 |
| Apr 14, 2025 | 1.7389 | 0.1250 | 7.75% | 1.6139 | 1.7389 | 1.6089 |
| Apr 11, 2025 | 1.5789 | 0.0250 | 1.61% | 1.5539 | 1.5989 | 1.5339 |
| Apr 10, 2025 | 1.5589 | 0.0050 | 0.32% | 1.5539 | 1.5689 | 1.4789 |
| Apr 9, 2025 | 1.5689 | 0.1650 | 11.75% | 1.4039 | 1.6189 | 1.4039 |
| Apr 8, 2025 | 1.4389 | -0.1750 | -10.84% | 1.6139 | 1.6139 | 1.4189 |
| Apr 7, 2025 | 1.5489 | 0.0650 | 4.38% | 1.4839 | 1.5889 | 1.4189 |
| Apr 4, 2025 | 1.5289 | -0.0100 | -0.65% | 1.5389 | 1.5489 | 1.4789 |
| Apr 3, 2025 | 1.5689 | -0.0250 | -1.57% | 1.5939 | 1.5939 | 1.5089 |
| Apr 2, 2025 | 1.6189 | 0.1400 | 9.47% | 1.4789 | 1.6489 | 1.4489 |
| Apr 1, 2025 | 1.4789 | -0.1300 | -8.08% | 1.6089 | 1.6089 | 1.4789 |
| Mar 31, 2025 | 1.5989 | -0.0600 | -3.62% | 1.6589 | 1.6589 | 1.5789 |
| Mar 28, 2025 | 1.6989 | -0.0400 | -2.30% | 1.7389 | 1.7389 | 1.6589 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Inovio Pharmaceuticals Company profile
Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system''s tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; QIAGEN N.V.; Coalition for Epidemic Preparedness Innovations; and Beijing Advaccine Biotechnology Co. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.| Industry: | Biotechnology & Medical Research (NEC) |
6769 Mesa Ridge Rd.
SAN DIEGO
CALIFORNIA 92121
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com